PINHONBIO® TECA 95%: a Centella profile with two distinct fractions

Develop with a defined Centella composition

Centella is a useful starting point for a botanical cosmetic brief, but the plant name does not define the material entering the formula. PINHONBIO® TECA 95% brings the constituent profile into the selection decision: asiaticoside together with the free acids asiatic acid and madecassic acid.

That distinction gives a development team a specific composition to evaluate and track. It also helps explain why a TECA prototype and a total-glycosides prototype should have separate material records, even when both originate from Centella.

What the supplied analytical record establishes

The supplied TECA COA reports HPLC ranges for asiaticoside and combined free genins. The free-genin definition names asiatic acid and madecassic acid. It does not set a fixed individual ratio for those two acids.

Use the percentage with its definition

TECA 95% is the grade designation used for this brief. The attached analytical record supports a 95.83% total for the supplied batch; that result is not a new ≥95% acceptance limit or a promise that every batch has identical composition.

In a prototype record, keep the fraction results alongside the overall total. This allows a later batch or material change to be assessed on the composition that matters to the study, rather than on the product name alone.

Resolve incorporation early

The current TECA product page describes limited water solubility and alcohol solubility. That makes the intended solvent system a useful first development question. A water-based format should not be treated as a direct transfer from a water-soluble total-glycosides grade.

Investigate incorporation in the selected vehicle and then in the complete formula. Observe uniformity, precipitation and the appearance of the stored prototype. Choose the solvent, temperature and addition sequence using the applicable technical guidance and trial results.

Build the application around a clear endpoint

For a Centella facial-care or skin-comfort concept, establish what the finished product is intended to deliver and how that will be assessed. In an emulsion, begin with incorporation and physical stability. In a serum concept, clarity or suspended-material behavior may be central to the first trial.

These are development scenarios, not tested recipes. Keep the composition study separate from any finished-product tolerability or performance assessment. The analytical profile provides a material definition, not evidence that a cosmetic has achieved a soothing or repair claim.

Carry the fractions into the sample brief

Ask for the specification and COA applicable to TECA 95%, plus the TDS and SDS needed for the intended process. Describe the vehicle and proposed product format. Retain the constituent results with the formula record so the next development decision can be traced to the material actually tested.

Sources & scope

• PINHONBIO: TECA constituent identity, solubility and technical-document requests

Supplier material reviewed October 4, 2026. This brief also uses the PINHONBIO-supplied TECA 95% COA reviewed on October 4, 2026. Specification ranges and the supplied batch results are distinguished below; General evaluation recommendations are editorial perspectives, not reported PINHONBIO test results.

Related reading